Screening in patients with increased risk of breast cancer (part 1): pros and cons of MRI screening
- PMID: 32241593
- DOI: 10.1016/j.rx.2020.01.007
Screening in patients with increased risk of breast cancer (part 1): pros and cons of MRI screening
Abstract
Screening plays an important role in women with a high risk of breast cancer. Given this population's high incidence of breast cancer and younger age of onset compared to the general population, it is recommended that screening starts earlier. There is ample evidence that magnetic resonance imaging (MRI) is the most sensitive diagnostic tool, and American and the European guidelines both recommend annual MRI screening (with supplementary annual mammography) as the optimum screening modality. Nevertheless, the current guidelines do not totally agree about the recommendations for MRI screening in some subgroups of patients. The first part of this article on screening in women with increased risk of breast cancer reviews the literature to explain and evaluate the advantages of MRI screening compared to screening with mammography alone: increased detection of smaller cancers with less associated lymph node involvement and a reduction in the rate of interval cancers, which can have an impact on survival and mortality (with comparable effects to other preventative measures). At the same time, however, we would like to reflect on the drawbacks of MRI screening that affect its applicability.
Keywords: Breast tumors; Cancer screening; Detección precoz de cáncer; Factores de riesgo; Genetic predisposition to disease; Magnetic resonance imaging; Mammography; Mamografía; Neoplasias mamarias; Predisposición genética a la enfermedad; Resonancia magnética; Risk factors; Sensibilidad y especificidad; Sensitivity and specificity.
Copyright © 2020 SERAM. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Screening in patients with increased risk of breast cancer (part 2). Where are we now? Actual MRI screening controversies.Radiologia (Engl Ed). 2020 Sep-Oct;62(5):417-433. doi: 10.1016/j.rx.2020.04.009. Epub 2020 Jun 9. Radiologia (Engl Ed). 2020. PMID: 32527577 Review. English, Spanish.
-
Mammography screening: A major issue in medicine.Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20. Eur J Cancer. 2018. PMID: 29272783
-
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17. Lancet Oncol. 2019. PMID: 31221620 Clinical Trial.
-
Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.J Natl Cancer Inst. 2020 Feb 1;112(2):136-144. doi: 10.1093/jnci/djz079. J Natl Cancer Inst. 2020. PMID: 31233143 Free PMC article.
-
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.Eur J Cancer. 2017 Nov;85:31-38. doi: 10.1016/j.ejca.2017.07.055. Eur J Cancer. 2017. PMID: 28886475 Review.
Cited by
-
Abbreviated magnetic resonance imaging in breast cancer: A systematic review of literature.Eur J Radiol Open. 2020 Dec 17;8:100307. doi: 10.1016/j.ejro.2020.100307. eCollection 2021. Eur J Radiol Open. 2020. PMID: 33364260 Free PMC article. Review.
-
Integrated analysis of diverse cancer types reveals a breast cancer-specific serum miRNA biomarker through relative expression orderings analysis.Breast Cancer Res Treat. 2024 Apr;204(3):475-484. doi: 10.1007/s10549-023-07208-3. Epub 2024 Jan 8. Breast Cancer Res Treat. 2024. PMID: 38191685 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous